A New Leadership Team is driving the unique advantages of PhaseOne Skin and Wound Cleanser

NASHVILLE, TN, October 25, 2023 /24-7PressRelease/ — PhaseOne Health is an innovative medical device company focused on providing
solutions for the reduction of microbial risks associated with surgical procedures and the treatment of wounds.

Jeffrey Nugent, PhaseOne Health President and CEO, has said, “I’m extremely confident that PhaseOne Skin and Wound Cleanser is providing superior advantages in the protection of microbial infections. Our team of medical and scientific advisors are among the most credible and experienced in this area and are aligned behind the independent data supporting our claims.”

Mr. Nugent has a broad background in medical and health-related businesses. His 25 years at Johnson & Johnson included leadership responsibilities across the medical device, pharmaceutical, and consumer segments, including Vice President of Worldwide Quality and the acquisition and leadership of Neutrogena. He has served as chairman, director, president, and CEO of several established and entrepreneurial companies. Mr Nugent added, “The PhaseOne team is one of the most talented and passionate I have worked with.”

The challenges related to combatting infections are among the most important in health care. The advantages of PhaseOne are based on the unique delivery of hypochlorous acid (HOCl). These include:

1. Highest available content of HOCl
2. High stability and purity maintained by unique UV light-blocking
3. A fast-acting anti-microbial that rapidly penetrates biofilm.

Jack Fisher, MD, PhaseOne Health Medical Director, and highly regarded plastic surgeon, has been focused on the understanding and development of PhaseOne for some time. Dr Fisher added, “We are committed to reducing the microbial risk and improving the outcomes of all plastic surgery procedures.

Dan Carlisle, VP of Innovation and Business Development, brings his extensive experience and knowledge of plastic surgery to the team’s overall credibility. Dan commented, “I’m proud of what we are doing and our contribution to the profession.”

PhaseOne was established in 2019 with the mission of providing the purest Hypochlorous Acid (HOCl) solution to healthcare providers and their patients. That’s why we manufacture our HOCl via a proprietary chemical manufacturing process. It’s also why we use UV-resistant amber glass. At PhaseOne Health, we care about getting it right. It’s why we go the extra mile and ask the next question. It’s also how we know that PhaseOne is the best.

Related Link:

For the original version of this press release, please visit 24-7PressRelease.com here